Status:
COMPLETED
A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.
Lead Sponsor:
Centocor, Inc.
Collaborating Sponsors:
Centocor BV
Conditions:
Ankylosing Spondylitis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
A study of the safety and efficacy of Infliximab (Remicade) versus placebo in subjects with Ankylosing Spondylitis
Detailed Description
This is a clinical research study that will determine if there is a reduction in the signs and symptoms (such as back pain and stiffness) of patients with ankylosing spondylitis with infliximab therap...
Eligibility Criteria
Inclusion
- Have had a diagnosis of definite Akylosing Spondylitis for at least 3 months prior to screening
- Have active disease with spinal pain
- receiving or intolerant to standard anti-inflammatory agents
Exclusion
- Have Rheumatoid Arthritis, systemic lupus erythematosus, or other inflammatory rheumatic disease
- Have a documented history of fibromyalgia
- Have total ankylosis
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2005
Estimated Enrollment :
279 Patients enrolled
Trial Details
Trial ID
NCT00207701
Start Date
September 1 2002
End Date
February 1 2005
Last Update
May 17 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.